[Editor’s note: the original version of this story referred only to adjuvant immunotherapy rather than the use of immunotherapy and targeted therapy as adjuvant treatment for high-risk melanoma. We apologise for the inaccuracy. The article has also been edited to clarify a statement relating to improvement across tumour and stage subgroups in Keynote 054.] Adjuvant ...
Adjuvant therapies provide ‘incredible’ outcomes in melanoma
By Sunalie Silva
10 Jun 2020